Johnson and Johnson combines Biosense with Cordis subsidiary:

Johnson & Johnson is to merge its Cordis Webster company with Biosense, an acquisition from last October. According to J&J, the move means the company, now to be known as Biosense Webster, will "better serve the needs of cardiologists" and apply its medical sensor technology. Cordis Webster was acquired in 1996 as part of the Cordis deal. The new company's worldwide president will be James Dennis, formerly president of St Jude's cardiac rhythm management division.